Dorothy Plaza, Registered Nurse - Diabetes Educator Medicare: Not Enrolled in Medicare Practice Location: 700 S Main St, Moscow, ID 83843 Phone: 208-883-6341 |
Mary Whitney Price, M.S., R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 401 Ponderosa Ct Apt 102, Moscow, ID 83843 Phone: 509-926-4984 |
Kimberly Ann Devich, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 803 S Main St, Moscow, ID 83843 Phone: 509-444-8200 |
Dr. Jonathan Holloway, DNP Registered Nurse Medicare: Medicare Enrolled Practice Location: 803 S Main St Ste 210, Moscow, ID 83843 Phone: 509-228-1000 Fax: 509-252-9300 |
Jaired Hudson, Registered Nurse - Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 1066 Nearing Rd, Moscow, ID 83843 Phone: 208-310-5186 |
Lacey Dawn Gettings, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 803 S Main St, Moscow, ID 83843 Phone: 208-848-8300 Fax: 208-822-5587 |
Amy Isbelle, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 803 S Main St, Moscow, ID 83843 Phone: 208-848-8300 |
Addison Taylor Weglin, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 700 S Main St, Moscow, ID 83843 Phone: 208-882-4511 |
News Archive
The bio-pharmaceutical marketplace - and the Oncology therapeutic area in particular - continues to evolve as new medicines and technologies create valuable market opportunities. It's in this competitive and challenging environment that organizations with new Oncology products are scrutinizing their strategies and tactics to support market education.
A U.S. and Korean research team has developed a chip-like device that could be scaled up to sort and store hundreds of thousands of individual living cells in a matter of minutes. The system is similar to a random access memory chip, but it moves cells rather than electrons.
RXi Pharmaceuticals Corporation, a recognized leader in RNAi-based therapeutic discovery and development, and Apthera, Inc., a private biotechnology company developing a pipeline of peptide-based immunotherapies for the adjuvant treatment of HER2-positive breast and other cancers, announced today the signing of a definitive merger agreement under which RXi will acquire Apthera.
Overall deaths from kidney cancer have now fallen across Europe after peaking in the early 1990s, according to a detailed analysis of mortality rates for 32 countries published in the urology journal BJU International.
The Ensign Group, Inc., the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, hospice care and assisted living companies, today reported record results for the fourth quarter and full year 2009.
› Verified 6 days ago